| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 04/22/2010 | CA2740728A1 Therapeutic antiviral peptides |
| 04/22/2010 | CA2739344A1 Phenethylamide derivatives and their heterocyclic analogues |
| 04/22/2010 | CA2738872A1 New benzimidazole derivatives |
| 04/22/2010 | CA2738609A1 Piperidine compounds, pharmaceutical composition comprising the same and its use |
| 04/21/2010 | EP2176235A2 A method of manufacturing 4'-[[4-methyl-6-(1-methyl-1h-benzimidazol-2-yl)-2-propyl-1h-benzimidazol-1yl]methyl]biphenyl-2-carboxylic acid (telmisartan) |
| 04/20/2010 | US7700638 Such as 7-(3-Chlorophenyl)-1-phenyl-5-trifluoromethylbenzimidazole; antianxiety agents; side effect reduction |
| 04/20/2010 | US7700618 2-{[1-(cyclopropylmethyl)-2-(2,2-dimethylpropyl)-1H-benzimidazol-5-yl]sulfonyl}-N,N,2-trimethylpropanamide; condition mediated by CB2 receptors; less toxicity, good absorption, distribution, solubility, metabolic stability, less protein binding affinity other than CB2 receptor, less drug-drug interaction |
| 04/20/2010 | CA2630009C Novel carboxylic acid derivatives and process for producing the same |
| 04/20/2010 | CA2419880C 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1h)one derivatives |
| 04/20/2010 | CA2417475C Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacterien |
| 04/15/2010 | WO2010042568A1 Processes for the preparation of bendamustine |
| 04/15/2010 | WO2010042475A1 Spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| 04/15/2010 | WO2010042473A1 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| 04/15/2010 | US20100093818 Benzimidazole derivatives |
| 04/15/2010 | US20100093767 Mitotic Kinase Inhibitors |
| 04/15/2010 | US20100093733 Amide and urea derivatives for the treatment of metabolic diseases |
| 04/15/2010 | CA2737495A1 Processes for the preparation of bendamustine |
| 04/14/2010 | EP2174933A2 Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same |
| 04/14/2010 | EP2174932A2 Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same |
| 04/14/2010 | EP2173721A1 A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles |
| 04/13/2010 | US7696214 Confining solid tumors; administering a tyrosine kinase inhibitor as antitumor agents; 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline |
| 04/13/2010 | US7696205 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; 4-Methylsulfanyl-N-{2-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-acetylamino]-cyclohexyl}-benzamide |
| 04/13/2010 | CA2336807C Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/08/2010 | WO2010039789A1 Spiro-imidazolone derivatives as glucagon receptor antagonists |
| 04/08/2010 | WO2010039668A2 Inhibitors of cyclin kinase inhibitor p21 |
| 04/08/2010 | WO2010018441A3 Process for the preparation of substantially pure telmisartan |
| 04/08/2010 | US20100087464 Protein kinase inhibitors and methods for using thereof |
| 04/08/2010 | US20100086955 Small Molecule Inhibitors of Ghrelin O-Acyltransferase |
| 04/08/2010 | CA2738663A1 Spiro-imidazolone derivatives as glucagon receptor antagonists |
| 04/07/2010 | EP2172459A1 Compound having hydantoin ring and method of producing the same |
| 04/07/2010 | EP2172454A1 Benzimidazole derivative |
| 04/07/2010 | EP2172450A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof |
| 04/07/2010 | EP2170836A1 Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors |
| 04/07/2010 | EP2170835A1 Process for preparing telmisartan |
| 04/07/2010 | EP2170823A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
| 04/07/2010 | EP2170814A2 Antibacterial agents |
| 04/07/2010 | EP2170260A1 Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres |
| 04/07/2010 | EP1987010B1 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 04/07/2010 | CN101691359A Method for synthesizing highly-pure bendamustine hydrochloride |
| 04/06/2010 | US7691860 Neuropeptide Y receptor antagonists; such as 2-(trans-4-tert-butylsulfonylaminocyclohexyl)-5-(trifluoromethyl)benzimidazole; bulimia, obesity, diabetes |
| 04/06/2010 | CA2566108C Proline derivatives and their use as dipeptidyl peptidase iv inhibitors |
| 04/06/2010 | CA2475137C New heterocyclic oxime derivatives, their preparation process and the pharmaceutical compositions that contain them |
| 04/01/2010 | WO2010036613A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 04/01/2010 | WO2010034796A1 1h-benz imidazole-5-carboxamides as anti-inflammatory agents |
| 04/01/2010 | WO2009129335A3 Selective inhibitors of histone deacetylase |
| 04/01/2010 | US20100081643 Novel cyclic benzimidazole derivatives useful as anti-diabetic agents |
| 04/01/2010 | US20100081203 Fluorescent isotope tags and their method of use |
| 04/01/2010 | CA2738083A1 1h-benzimidazole-5-carboxamides as anti-inflammatory agents |
| 04/01/2010 | CA2737694A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 03/31/2010 | EP2166856A1 Chemical compounds |
| 03/31/2010 | CN101687815A a regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles |
| 03/31/2010 | CN101687814A heterocyclic bridged biphenyls |
| 03/30/2010 | US7687639 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide |
| 03/30/2010 | US7687638 C-(3-Methyl-5-phenyl-3H-benzoimidazol-4-yl)-methylamine; diabetes, fasting plasma glucose (IFG), metabolic acidosis, ketosis, appetite regulation, obesity, immunosuppressants or cytokine release regulation, autoimmune diseases such as inflammatory bowel disease, multiple sclerosis and arthritis |
| 03/30/2010 | US7687529 treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders; 1'-[3-(methylamino)-1-phenylpropyl]spiro[cyclohexane-1,3'-indol]-2'(1'H)-one |
| 03/25/2010 | WO2010032461A1 Nitrogen-containing fused ring compound |
| 03/25/2010 | WO2010009405A9 Targeted nitroxide agents |
| 03/25/2010 | US20100076041 Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors |
| 03/25/2010 | US20100075993 Small molecule inhibitors against west nile virus replication |
| 03/25/2010 | US20100071769 Fluorene derivatives and organic electronic device using the same |
| 03/24/2010 | EP2164832A1 Process for preparing 2-(2-pyridylmethyl)-sulfinyl-1h-benzimidazoles and the intermediate compounds used therein |
| 03/24/2010 | EP2164828A2 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation |
| 03/24/2010 | EP1966157B1 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors |
| 03/24/2010 | CN101679301A Process for preparing 2-(2-pyridylmethyl)-sulfinyl-1h-benzimidazoles and the intermediate compounds used therein |
| 03/24/2010 | CN101679300A Crystalline 1-(cyclohexyloxycarbonyloxy) ethyl 1-((2'-cyanobiphenyl-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate and a process for its preparation |
| 03/24/2010 | CN101679299A Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5 |
| 03/24/2010 | CN101679298A fused bicyclic heteroaryl derivatives |
| 03/24/2010 | CN101675927A therapeutic molecules and methods-1 |
| 03/23/2010 | CA2352436C Polymorphs of telmisartan, processes for preparing them and their use in the preparation of a pharmaceutical composition |
| 03/18/2010 | WO2010030891A2 Aryl guanidine f1f0-atpase inhibitors and related methods |
| 03/18/2010 | WO2010028981A1 New benzimidazole derivatives |
| 03/18/2010 | US20100069453 Certain Chemical Entities, Compositions, and Methods |
| 03/18/2010 | US20100069405 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 03/18/2010 | US20100066243 Organic electroluminescent device and indole derivative |
| 03/18/2010 | US20100064450 Agent for dyeing keratin-containing fibers |
| 03/18/2010 | CA2734034A1 New benzimidazole derivatives |
| 03/17/2010 | EP2162442A1 Dual-acting benzoimidazole antihypertensive agents |
| 03/17/2010 | CN101675036A dual-acting benzoimidazole antihypertensive agents |
| 03/17/2010 | CN101671308A Method for preparing 2-aminoalkylbenzimidazole derivatives |
| 03/17/2010 | CN101671307A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors |
| 03/16/2010 | US7678474 Imidazole derivatives and organic electronic device using the same |
| 03/11/2010 | WO2010028159A2 Transition metal-catalyzed c-h amination using unactivated amines |
| 03/11/2010 | WO2010028032A2 Process for synthesis of imidazolium and benzimidazolium surfactants and their use in clays and nanocomposites |
| 03/11/2010 | WO2010027181A2 Anthracene derivative and organic electroluminescence element using the same |
| 03/11/2010 | US20100063122 NOVEL 2-(2-HYDROXYPHENYL)BENZIMlDAZOLES USEFUL FOR TREATING OBESITY AND DIABETES |
| 03/11/2010 | US20100063101 New benzimidazole derivatives |
| 03/10/2010 | EP2161239A1 Semiconductor nanocrystals |
| 03/10/2010 | EP2160380A1 Cyano-guanidine derivatives as glutaminyl cyclase inhibitors |
| 03/10/2010 | CN101665465A Thrombase inhibitor containing guanidyl heterocyclic compound and preparation method thereof |
| 03/09/2010 | US7674809 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production |
| 03/09/2010 | CA2336702C Sulfonylaminocarboxylic acid n-arylamides as guanylate cyclase activators |
| 03/04/2010 | US20100056592 Prodrugs of (3,5-bis(4-fluorophenyl)tetrahydro-1h-oxazolo[3,4-c]oxazol-7a-yl)methanol and derivatives thereof |
| 03/04/2010 | US20100056545 Novel phenylacetate derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and composition for prevention or treatment of diseases induced by activation of t-type calcium ion channel containing the same as an active ingredient |
| 03/04/2010 | US20100056525 5- and 6- substituted benzimidazole thiophene compounds |
| 03/04/2010 | US20100056515 Benzimidazole compounds |
| 03/03/2010 | EP1100801B1 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 02/25/2010 | US20100048914 Novel C-17-Heteroaryl Steroidal Cyp17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity |
| 02/25/2010 | US20100048913 Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity |
| 02/25/2010 | US20100048912 Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity |
| 02/25/2010 | US20100048893 Substituted arylalkanoic acid derivatives and use thereof |